Glucagon Market Report Probes the USD Million Size, Share, Growth Report and Future Analysis by 2032

Key Insights

The Glucagon Market size was valued at USD 278.5 USD Million in 2023 and is projected to reach USD 441.39 USD Million by 2032, exhibiting a CAGR of 6.8 % during the forecast period. When the levels of glucose in the blood become too low, Glucagon, a peptide hormone produced by the pancreas, activates the release of glucose from the liver to maintain a normal level of blood sugar. It has two primary types: glucagon-\alpha and -\beta. In cases where glucose levels dip due to fasting or hypoglycemia, alpha glucagon promotes the conversion of stored glycogen in the liver into glucose, easing the release of the product back into the bloodstream to boost glucose levels. Gamma-glucagon also plays an important role in digestion by acting on the release of gastric acid and enzymes. With respect to physical function, synthetic glucagon, besides medicine, has a variety of functions, primarily, in the treatment of severe hypoglycemia, an emergency situation that occurs in patients with diabetes with low blood sugar

Glucagon Trends

• Increasing prevalence of diabetes
• Growing awareness about glucagon therapy
• Technological advancements in glucagon delivery systems

Driving Forces: What's Propelling the Glucagon Market

• Surging Prevalence of Diabetes: The increasing incidence of type 1 and type 2 diabetes globally fuels the demand for glucagon as an emergency treatment for severe hypoglycemia.
• Government Support for Diabetes Management: Governments worldwide are actively promoting diabetes management initiatives, including expanded access to glucagon and educational programs, to reduce the burden of the disease.
• Technological Advancements in Glucagon Delivery: Pharmaceutical companies are continuously investing in research and development to improve glucagon formulations, making them more convenient, effective, and accessible to patients.
• Increased Awareness and Education: Growing awareness about the importance of hypoglycemia management and the benefits of glucagon therapy drives market growth. Educational campaigns and patient support groups play a crucial role in disseminating information and reducing treatment barriers.
• Expanding Access and Coverage: Governments and insurance companies are expanding access to glucagon by including it in formularies and reducing cost barriers. This ensures that patients have timely access to this lifesaving medication.

Challenges and Restraints in Glucagon Market

• High cost of glucagon therapy
• Availability of alternative treatments for hypoglycemia
• Limited access to glucagon in developing countries

Emerging Trends in Glucagon

• Development of nasal glucagon products
• Advances in continuous glucose monitoring systems
• Growing adoption of telemedicine for glucagon management

Growth Catalysts in Glucagon Industry

• Increasing adoption of glucagon in emergency situations
• Rising demand for self-injectable glucagon devices
• Government reimbursement policies supporting glucagon therapy

Market Segmentation: Glucagon Analysis

Route of Administration:

• Injectable
• Inhalation

Application:

• Hypoglycemia
• Diagnostic Aid

Distribution Channel:

• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies

Leading Players in the Glucagon Market

• Novo Nordisk A/S
• Fresenius SE & Co. KGaA
• Amphastar Pharmaceuticals, Inc.
• Xeris Biopharma Holdings, Inc.
• ILS Inc.
• United Biotech (P) Limited
• Zealand Pharma A/S
• Taj Pharmaceuticals Limited

Significant Developments in the Glucagon Sector

• June 2023: Amphastar Pharmaceuticals, Inc. acquired BAQSIMI from Eli Lilly and Company.
• November 2022: Tetris Pharma Ltd. launched Ogluo in Germany.
• March 2021: Zealand Pharma received approval for Zegalogue from the U.S. FDA.
• January 2021: Baqsimi received marketing authorization from the European Commission.
• December 2020: Amphastar Pharmaceuticals, Inc. received approval for its new drug application of glucagon for Injection Emergency Kit.

Comprehensive Coverage Glucagon Market Report

This report provides:

• Market size and forecast
• Competitive landscape
• Product analysis
• Regional analysis
• Emerging trends
• Growth drivers and challenges

Regional Insight

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

DROCT

• Drivers: Increasing diabetes prevalence, technological advancements
• Restraints: High cost of therapy
• Opportunities: Emerging markets, new product development
• Challenges: Access to glucagon in developing countries
• Threats: Alternative treatments for hypoglycemia

Pricing Analysis

Factors influencing glucagon pricing:

• Manufacturing costs
• Research and development expenses
• Competition
• Regulatory approvals

Import And Export Analysis

Major import and export countries:

• United States
• Europe
• China
• India

Segmentation

By Route of Administration

• Injectable
• Inhalation

By Application

• Hypoglycemia
• Diagnostic Aid

By Distribution Channel

• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies